Track Pulmuone , Ltd.'s EBIT ($100B) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
As of the most recent data (June 2026), 017810.KS shows a EBIT of $100B. That compares with $460B in the prior-year period — down 77.9% year over year. That is below the sector sector average of $2.6T. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 017810.KS's EBIT is now $100B (was $460B) — a 77.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pulmuone , Ltd. is outperforming or lagging.
The its sector sector average EBIT is about $2.6T. Pulmuone , Ltd. is at $100B, which is lower that average. That is roughly 96.0% below the sector mean. Use the comparison chart on this page to see how 017810.KS stacks up against individual peers as well.
Tracking 017810.KS's ebit over time shows whether Pulmuone , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $100B That compares with $460B in the prior-year period — down 77.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Pulmuone , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $100B) with ownership activity and broader fundamentals.